Free Trial

Baxter International (BAX) Competitors

$33.44
+0.25 (+0.75%)
(As of 05/30/2024 ET)

BAX vs. BDX, EW, DXCM, IDXX, RMD, STE, HOLX, PODD, TFX, and GMED

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD), Teleflex (TFX), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Becton, Dickinson and Company (NYSE:BDX) and Baxter International (NYSE:BAX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Baxter International has lower revenue, but higher earnings than Becton, Dickinson and Company. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$19.37B3.38$1.48B$4.5449.95
Baxter International$14.81B1.15$2.66B$5.206.43

Becton, Dickinson and Company presently has a consensus price target of $280.17, indicating a potential upside of 23.54%. Baxter International has a consensus price target of $44.42, indicating a potential upside of 32.82%. Given Becton, Dickinson and Company's higher possible upside, analysts clearly believe Baxter International is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Baxter International
0 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.18

In the previous week, Becton, Dickinson and Company had 2 more articles in the media than Baxter International. MarketBeat recorded 24 mentions for Becton, Dickinson and Company and 22 mentions for Baxter International. Baxter International's average media sentiment score of 0.54 beat Becton, Dickinson and Company's score of 0.40 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
10 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Baxter International
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Becton, Dickinson and Company pays an annual dividend of $3.80 per share and has a dividend yield of 1.7%. Baxter International pays an annual dividend of $1.16 per share and has a dividend yield of 3.5%. Becton, Dickinson and Company pays out 83.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Baxter International pays out 22.3% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 52 consecutive years and Baxter International has raised its dividend for 8 consecutive years. Baxter International is clearly the better dividend stock, given its higher yield and lower payout ratio.

Becton, Dickinson and Company has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500.

Baxter International received 139 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.12% of users gave Baxter International an outperform vote while only 62.33% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Becton, Dickinson and CompanyOutperform Votes
589
62.33%
Underperform Votes
356
37.67%
Baxter InternationalOutperform Votes
728
66.12%
Underperform Votes
373
33.88%

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.3% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Baxter International has a net margin of 17.79% compared to Baxter International's net margin of 6.76%. Becton, Dickinson and Company's return on equity of 18.47% beat Baxter International's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company6.76% 13.90% 6.73%
Baxter International 17.79%18.47%4.91%

Summary

Baxter International beats Becton, Dickinson and Company on 11 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$17.04B$3.83B$5.04B$17.55B
Dividend Yield3.43%1.79%2.84%3.53%
P/E Ratio6.4316.00165.9825.81
Price / Sales1.1573.942,437.8910.43
Price / Cash6.4647.9135.0619.29
Price / Book2.075.035.585.86
Net Income$2.66B$4.50M$105.68M$976.92M
7 Day Performance-1.68%1.10%0.89%0.92%
1 Month Performance-17.17%1.19%3.03%4.70%
1 Year Performance-17.08%17.90%6.15%23.18%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
4.9033 of 5 stars
$226.85
-0.8%
$281.40
+24.0%
-4.8%$65.56B$19.37B49.9773,000Analyst Forecast
Short Interest ↓
EW
Edwards Lifesciences
4.709 of 5 stars
$87.04
-1.1%
$94.31
+8.4%
+7.9%$52.45B$6.00B37.5219,800Analyst Forecast
Insider Selling
Short Interest ↓
DXCM
DexCom
4.9661 of 5 stars
$127.38
+0.0%
$141.67
+11.2%
+4.3%$50.66B$3.62B82.189,600Analyst Forecast
Short Interest ↓
IDXX
IDEXX Laboratories
4.3705 of 5 stars
$505.40
-2.1%
$580.38
+14.8%
+7.2%$41.74B$3.66B48.9311,000Positive News
RMD
ResMed
4.464 of 5 stars
$207.17
-2.9%
$202.80
-2.1%
-0.3%$30.44B$4.22B31.8210,140Analyst Revision
STE
STERIS
4.0234 of 5 stars
$223.39
-2.5%
$241.60
+8.2%
+11.9%$22.07B$5.14B58.4817,100Analyst Downgrade
Analyst Revision
HOLX
Hologic
4.7751 of 5 stars
$73.36
-0.6%
$85.60
+16.7%
-7.7%$17.12B$3.96B37.436,990
PODD
Insulet
4.9008 of 5 stars
$177.82
-1.2%
$239.44
+34.7%
-35.5%$12.45B$1.70B53.883,000Analyst Forecast
Insider Selling
Short Interest ↑
TFX
Teleflex
4.2967 of 5 stars
$204.64
-0.8%
$261.75
+27.9%
-11.0%$9.64B$2.97B32.8514,500Short Interest ↑
High Trading Volume
GMED
Globus Medical
4.7026 of 5 stars
$65.48
-0.5%
$68.50
+4.6%
+26.6%$8.86B$1.90B102.315,000Analyst Forecast
Short Interest ↓
Analyst Revision
Positive News

Related Companies and Tools

This page (NYSE:BAX) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners